TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34972618

Group type: EXPERIMENTAL
Intervention: Deep supra‐temporalis muscle subfascial approach (DSFA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional fascial approach (TFA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (DSFA and TFA)
Number of subjects: 30
Study: 34534926

Group type: EXPERIMENTAL
Intervention: Single-subject GM networks analysis
Number of subjects: 51
Study: 35367850

Group type: EXPERIMENTAL
Intervention: Textured insoles
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo insoles
Number of subjects: 30

Group type: COMPARATOR
Intervention: Smooth (control) insoles
Number of subjects: 30
Study: 32594300

Group type: EXPERIMENTAL
Intervention: Autologous hematopoietic stem cell transplantation (HSCT)
Number of subjects: 60
Study: 34184795

Group type: EXPERIMENTAL
Intervention: On-line self-help intervention consisting of 10 modules based on cognitive-behavioral therapy and motivational interviewing.
Number of subjects: 589

Group type: COMPARATOR
Intervention: Active control group received access to a website with a self-test including personalized normative feedback and information for standard alcohol treatment.
Number of subjects: 589
Study: 34263533

Group type: EXPERIMENTAL
Intervention: Curriculum-based intervention founded on the elaboration likelihood model (ELM)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Education-based control intervention
Number of subjects: 101
Study: 32168090

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation sessions
Number of subjects: 49
Study: 35305810

Group type: EXPERIMENTAL
Intervention: UG (ultrasound group)
Number of subjects: 79

Group type: COMPARATOR
Intervention: CG (control group)
Number of subjects: 79
Study: 34978774

Group type: EXPERIMENTAL
Intervention: Levothyroxine treatment in patients with SCH
Number of subjects: 54

Group type: COMPARATOR
Intervention: Healthy controls (HC)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Subclinical hypothyroidism (SCH)
Number of subjects: 54
Study: 36062550

Group type: COMPARATOR
Intervention: Standard-care intervention (testing and phone feedback)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Experimental intervention (testing and in-person feedback with care-coordinator calls)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Low-risk group (no intervention)
Number of subjects: 119
Study: 34154759

Group type: EXPERIMENTAL
Intervention: ivabradine 5 mg twice daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 32938746

Group type: COMPARATOR
Intervention: SGLT2 inhibitors
Number of subjects: 216558

Group type: COMPARATOR
Intervention: GLP-1 receptor agonists
Number of subjects: 216558

Group type: COMPARATOR
Intervention: DPP-4 inhibitors
Number of subjects: 216558
Study: 615916032

Group type: EXPERIMENTAL
Intervention: 5% PVI
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 10% PVI
Number of subjects: 120

Group type: COMPARATOR
Intervention: Moxifloxacin (preoperative)
Number of subjects: 120
Study: 34524700

Group type: EXPERIMENTAL
Intervention: Rivaroxaban for thromboprophylaxis
Number of subjects: 76

Group type: COMPARATOR
Intervention: Acetylsalicylic acid
Number of subjects: 76
Study: 32776980

Group type: EXPERIMENTAL
Intervention: Spousal communication about contraception
Number of subjects: 1020

Group type: EXPERIMENTAL
Intervention: Wives' reports of spousal communication
Number of subjects: 1020

Group type: EXPERIMENTAL
Intervention: Husbands' reports of spousal communication
Number of subjects: 1020
Study: 35590307

Group type: EXPERIMENTAL
Intervention: Bamboo salt herbal toothpaste
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional non‐herbal toothpaste
Number of subjects: 60
Study: 33361414

Group type: EXPERIMENTAL
Intervention: E-learning package
Number of subjects: 97

Group type: COMPARATOR
Intervention: Lecture-based teaching
Number of subjects: 97
Study: 32456679

Group type: EXPERIMENTAL
Intervention: Self-sampling for HPV testing
Number of subjects: 868
Study: 36043784

Group type: EXPERIMENTAL
Intervention: OEP (OEPG; n=12)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: OEP plus DT (OEPDTG; n=12)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control Group (CG; n=12)
Number of subjects: 36
Study: 32768283

Group type: EXPERIMENTAL
Intervention: Cardiometabolic risk factors (CMRF) prevalence
Number of subjects: 3414
Study: 34352501

Group type: EXPERIMENTAL
Intervention: Multilayer perceptron classifier (MLPC) modeling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Support vector machine (SVM)
Number of subjects: 0
Study: 33651896

Group type: EXPERIMENTAL
Intervention: Lidocaine infusion (1.5 mg.kg-1 bolus, 2 mg.kg-1.h-1 infusion intra-operatively, 1.33 mg.kg-1.h-1 subcutaneous infusion postoperatively for up to 12 hours)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Lidocaine infusion
Number of subjects: 150
Study: 33127948

Group type: EXPERIMENTAL
Intervention: Mixed exercise program (balance exercise plus resistance exercise)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Resistance exercise
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mixed exercise program
Number of subjects: 60
Study: 34747977

Group type: EXPERIMENTAL
Intervention: Oral nadolol
Number of subjects: 71

Group type: COMPARATOR
Intervention: Oral propranolol
Number of subjects: 71
Study: 33063610

Group type: EXPERIMENTAL
Intervention: Histamine H3 receptor gene variants (specifically rs3787430 and rs74627870)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Histamine H3 receptor gene variant (rs13042865)
Number of subjects: 248
Study: 33188301

Group type: EXPERIMENTAL
Intervention: Healthy Low Carbohydrate (HLC) diet
Number of subjects: 609

Group type: COMPARATOR
Intervention: Healthy Low Fat (HLF) diet
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Healthy Low Carbohydrate (HLC) diet (men)
Number of subjects: 609

Group type: COMPARATOR
Intervention: Healthy Low Fat (HLF) diet (women)
Number of subjects: 609
Study: 35017254

Group type: EXPERIMENTAL
Intervention: ONCO-TreC electronic diary
Number of subjects: 136

Group type: COMPARATOR
Intervention: Standard paper diary
Number of subjects: 136
Study: 33863665

Group type: EXPERIMENTAL
Intervention: CardioMEMS treatment in patients with PAPP ≤ 0.583
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: CardioMEMS treatment in patients with HFrEF and PAPP ≤ 0.583
Number of subjects: 550

Group type: COMPARATOR
Intervention: CardioMEMS treatment in patients with PAPP > 0.583 or HF with preserved EF (HFpEF)
Number of subjects: 550
Study: 35341615

Group type: EXPERIMENTAL
Intervention: Strengths-Based Case Management (SBCM)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Screening, Assessment, and Referral (SAR)
Number of subjects: 300
Study: 34751657

Group type: EXPERIMENTAL
Intervention: ePRO (electronic PRO)
Number of subjects: 678

Group type: COMPARATOR
Intervention: P&P (paper-and-pencil)
Number of subjects: 678

Group type: COMPARATOR
Intervention: P&P
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: ePRO
Number of subjects: 678
Study: 35443727

Group type: EXPERIMENTAL
Intervention: Nurse navigation program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 0
Study: 34248041

Group type: EXPERIMENTAL
Intervention: Modified dose of terlipressin (response-guided titration method)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Standard dosage of terlipressin
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Modified dose of terlipressin
Number of subjects: 161
Study: 32825846

Group type: EXPERIMENTAL
Intervention: Various healthcare interventions in RCTs
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Freely available Bayesian prediction model
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: User-friendly tool for trial investigators
Number of subjects: 300
Study: 34117147

Group type: EXPERIMENTAL
Intervention: NPWT
Number of subjects: 539

Group type: COMPARATOR
Intervention: CWT
Number of subjects: 539
Study: 34976609

Group type: EXPERIMENTAL
Intervention: Online skin self-examination (SSE) education
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Active control arm
Number of subjects: 1000
Study: 36420366

Group type: EXPERIMENTAL
Intervention: Cervical spine manipulation (SM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Muscle energy technique (MET)
Number of subjects: 50
Study: 33203449

Group type: EXPERIMENTAL
Intervention: Digital crowdsourced intervention including 24 images and four short videos about HIV testing and safe sexual behaviors, and HIV self-test services provided by the study team.
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group (not specified in detail in the abstract).
Number of subjects: 500
Study: 36214479

Group type: EXPERIMENTAL
Intervention: Demisexual individuals
Number of subjects: 119181

Group type: EXPERIMENTAL
Intervention: Pansexual individuals
Number of subjects: 119181

Group type: EXPERIMENTAL
Intervention: Gender nonconforming FAB individuals
Number of subjects: 119181

Group type: COMPARATOR
Intervention: All other sexual and gender identity groups
Number of subjects: 119181
Study: 33956075

Group type: EXPERIMENTAL
Intervention: Aflibercept (4 monthly injections)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Vitrectomy with panretinal photocoagulation (PRP)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Aflibercept
Number of subjects: 205

Group type: COMPARATOR
Intervention: Vitrectomy with PRP
Number of subjects: 205
Study: 32893274

Group type: EXPERIMENTAL
Intervention: McCoy laryngoscope
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope
Number of subjects: 90

Group type: COMPARATOR
Intervention: C-MAC video-laryngoscope
Number of subjects: 90
Study: 34137277

Group type: EXPERIMENTAL
Intervention: Iliac crest bone graft
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bovine-derived demineralized bone matrix (DMBM)
Number of subjects: 20
Study: 34920553

Group type: EXPERIMENTAL
Intervention: Physical telerehabilitation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Periodic newsletters (Control)
Number of subjects: 0
Study: 35867859

Group type: EXPERIMENTAL
Intervention: Steroidal mineralocorticoid receptor antagonists (MRAs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34616489

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg plus best supportive care (BSC)
Number of subjects: 413

Group type: COMPARATOR
Intervention: Placebo plus best supportive care (BSC)
Number of subjects: 413
Study: 32493715

Group type: EXPERIMENTAL
Intervention: Higher AMY1 genetic risk score (GRS) with high dietary carbohydrate intake
Number of subjects: 32054

Group type: EXPERIMENTAL
Intervention: Higher AMY1 genetic risk score (GRS) with low dietary carbohydrate intake
Number of subjects: 32054

Group type: EXPERIMENTAL
Intervention: Randomized dietary intervention over 2 years
Number of subjects: 32054
Study: 35771645

Group type: EXPERIMENTAL
Intervention: Intensified training
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Taper period after intensified training
Number of subjects: 23
Study: 34497078

Group type: EXPERIMENTAL
Intervention: Adjunctive use of an internet-based self-management intervention (priovi)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Care as usual (CAU) by treating psychiatrist and/or psychotherapist
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 204
Study: 32012453

Group type: EXPERIMENTAL
Intervention: 1-month DAPT
Number of subjects: 813

Group type: COMPARATOR
Intervention: >1-month DAPT
Number of subjects: 813
Study: 35267951

Group type: EXPERIMENTAL
Intervention: Behavioral weight loss (BWL) treatment for 4 months
Number of subjects: 82
Study: 33619569

Group type: EXPERIMENTAL
Intervention: Covariable-adjusted summary associations in two-sample Mendelian randomization (MR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjustment of waist circumference for body mass index
Number of subjects: 0
Study: 32780921

Group type: EXPERIMENTAL
Intervention: 12-week alarm management training course based on the theory of planned behaviour
Number of subjects: 93

Group type: COMPARATOR
Intervention: Regular training (Control)
Number of subjects: 93
Study: 35146039

Group type: EXPERIMENTAL
Intervention: V114 (15-valent pneumococcal conjugate vaccine)
Number of subjects: 1515

Group type: COMPARATOR
Intervention: PCV13 (13-valent pneumococcal conjugate vaccine)
Number of subjects: 1515

Group type: EXPERIMENTAL
Intervention: PPSV23 (23-valent pneumococcal polysaccharide vaccine)
Number of subjects: 1515

Group type: EXPERIMENTAL
Intervention: V114 and PCV13
Number of subjects: 1515
Study: 34873046

Group type: EXPERIMENTAL
Intervention: Empathy-based counterspeech
Number of subjects: 1350

Group type: COMPARATOR
Intervention: Humor-based counterspeech
Number of subjects: 1350

Group type: COMPARATOR
Intervention: Warning of consequences-based counterspeech
Number of subjects: 1350
Study: 37021410

Group type: EXPERIMENTAL
Intervention: 10 mg ezetimibe (EZE) tablets (test product)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 10 mg ezetimibe (EZE) tablets (reference product)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both test and reference products
Number of subjects: 24
Study: 33212159

Group type: EXPERIMENTAL
Intervention: Bumetanide
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 32890814

Group type: EXPERIMENTAL
Intervention: Stepping Stones Creating Futures (SSCF) intervention
Number of subjects: 15
Study: 35695720

Group type: EXPERIMENTAL
Intervention: Paliperidone ER (6-15 mg/d)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Olanzapine (10-30 mg/d)
Number of subjects: 86
Study: 34023351

Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir (G/P) for 12 or 16 weeks
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir (G/P) with ribavirin for 12 weeks
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir (G/P) for 16 weeks
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Treatment-emergent NS3 RASs
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Treatment-emergent NS5A RASs
Number of subjects: 177
Study: 32575945

Group type: EXPERIMENTAL
Intervention: Targeted artery perfusion of verapamil and chemotherapy drugs
Number of subjects: 60

Group type: COMPARATOR
Intervention: Targeted artery perfusion of chemotherapy drugs alone (Control)
Number of subjects: 60
Study: 35692038

Group type: EXPERIMENTAL
Intervention: Vitamin D (100 unit/kg/day)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Zinc (20 mg/day)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control (hypertonic saline only)
Number of subjects: 94
Study: 33707050

Group type: EXPERIMENTAL
Intervention: Target Exposure Index (EIT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Deviation Index (DI)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Default values for EIT
Number of subjects: 10

Group type: COMPARATOR
Intervention: Acceptable EI range
Number of subjects: 10
Study: 35643717

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 34930979

Group type: EXPERIMENTAL
Intervention: Tenoten (4 tablets/day)
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Tenoten (8 tablets/day)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 390
Study: 35947279

Group type: EXPERIMENTAL
Intervention: Biofeedback-guided pelvic floor exercise therapy (BFT)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Dapoxetine 30 mg
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Combination of BFT and dapoxetine 30 mg
Number of subjects: 65

Group type: COMPARATOR
Intervention: Comparison between groups
Number of subjects: 65
Study: 33536096

Group type: EXPERIMENTAL
Intervention: Oily fish consumption (about 300 g/week for 12 weeks)
Number of subjects: 199
Study: 36167363

Group type: EXPERIMENTAL
Intervention: Low-dose high-intensity training (1×4 min intervals at ~90% of maximal heart rate and 2×4 repetitions strength training at ~90% of 1 repetition maximum)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High-dose high-intensity training (4×4 min intervals at ~90% of maximal heart rate and 4×4 repetitions strength training at ~90% of 1 repetition maximum)
Number of subjects: 40
Study: 33683035

Group type: EXPERIMENTAL
Intervention: Biochar (B) + Poultry Manure (PM) + Urea
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Poultry Manure (PM)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Biochar (B)
Number of subjects: 15
Study: 32638463

Group type: EXPERIMENTAL
Intervention: Intralesional injection of botulinum toxin type A once a month for 4 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Four sessions of CO2 laser therapy at 1 month interval followed by topical application of botulinum toxin A
Number of subjects: 20
Study: 36079824

Group type: EXPERIMENTAL
Intervention: Yoghurt intake (175 g of plain organic milk yoghurt daily for 8 weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Self-selected diet (Control group)
Number of subjects: 52
Study: 33661692

Group type: EXPERIMENTAL
Intervention: Perspective-change intervention
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group (no perspective-change intervention)
Number of subjects: 155
Study: 35798751

Group type: EXPERIMENTAL
Intervention: Specialist nail drops
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Standard care
Number of subjects: 105

Group type: COMPARATOR
Intervention: Nail polish
Number of subjects: 105
Study: 33782047

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 0
Study: 32069218

Group type: EXPERIMENTAL
Intervention: Paleolithic diet with added exercise (PDEX)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Paleolithic diet (PD)
Number of subjects: 28
Study: 34763338

Group type: COMPARATOR
Intervention: 3% Hypertonic Saline (HS), 5 mL/kg as continuous infusion, titrated every 6 hours to achieve serum sodium of <160 (Group A; n = 26)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 20% Mannitol (MT), 1 g/kg as IV bolus, repeated every 6 hours (Group B; n = 25)
Number of subjects: 51
Study: 34404237

Group type: EXPERIMENTAL
Intervention: DAPT using cilostazol and clopidogrel
Number of subjects: 1879

Group type: COMPARATOR
Intervention: Clopidogrel-monotherapy
Number of subjects: 1879

Group type: EXPERIMENTAL
Intervention: DAPT using cilostazol and aspirin
Number of subjects: 1879

Group type: COMPARATOR
Intervention: Aspirin-monotherapy
Number of subjects: 1879
Study: 33119477

Group type: EXPERIMENTAL
Intervention: Experimental group: radiation with capecitabine combined with weekly irinotecan (80 mg/m2 for UGT1A1*1*1 or 65 mg/m2 for UGT1A1*1*28)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Control group: pelvic radiation of 50 Gy/25 fractions with concurrent capecitabine, followed by oxaliplatin and capecitabine
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 356

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 356
Study: 35876837

Group type: EXPERIMENTAL
Intervention: Bright light therapy (BLT) for 30 minutes in the morning at 10,000 lux for 6 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Dim red light (DRL) for 30 minutes in the morning at 19 lux for 6 weeks
Number of subjects: 22
Study: 33574141

Group type: EXPERIMENTAL
Intervention: Targeted spatial navigation intervention (5 hours/week for 16 weeks, total: 80 hours)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Active control group (watching educational videos and answering subjective questions)
Number of subjects: 84
Study: 35238694

Group type: EXPERIMENTAL
Intervention: Auditory feedback during active reaching task
Number of subjects: 20

Group type: COMPARATOR
Intervention: No auditory feedback during active reaching task
Number of subjects: 20
Study: 34288404

Group type: EXPERIMENTAL
Intervention: Dextrose (DEX) dietary challenge
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-fat (HF) dietary challenge
Number of subjects: 20
Study: 35802667

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 232

Group type: COMPARATOR
Intervention: Everolimus
Number of subjects: 232
Study: 34928990

Group type: EXPERIMENTAL
Intervention: Eculizumab (900 mg doses, two doses)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (standard therapy)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Eculizumab
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control
Number of subjects: 75
Study: 34387823

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise for 6 weeks
Number of subjects: 101

Group type: COMPARATOR
Intervention: Personalized diabetes diet intervention, online education, and routine prenatal care (Control)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise
Number of subjects: 101
Study: 32365359

Group type: EXPERIMENTAL
Intervention: RHB-105 (amoxicillin, 3 g; omeprazole, 120 mg; and rifabutin, 150 mg)
Number of subjects: 455

Group type: COMPARATOR
Intervention: Active comparator (amoxicillin, 3 g, and omeprazole, 120 mg)
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: RHB-105
Number of subjects: 455

Group type: COMPARATOR
Intervention: Active comparator
Number of subjects: 455
Study: 33899589

Group type: EXPERIMENTAL
Intervention: ePRO group (continuous electronic patient-reported outcomes at home)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: ePRO group
Number of subjects: 102

Group type: COMPARATOR
Intervention: paper-based group (standard practice)
Number of subjects: 102
Study: 34431601

Group type: EXPERIMENTAL
Intervention: Personal genomic educational testing (PGET)
Number of subjects: 233

Group type: COMPARATOR
Intervention: No personal genomic educational testing (NPGET)
Number of subjects: 233
Study: 32511110

Group type: EXPERIMENTAL
Intervention: 12-week home-based telehealth exercise training program
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual lifestyles (control group)
Number of subjects: 50
Study: 34344171

Group type: EXPERIMENTAL
Intervention: FitBit + SparkPeople
Number of subjects: 44

Group type: COMPARATOR
Intervention: FitBit only
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Self-monitoring, goal setting, and self-efficacy
Number of subjects: 44
Study: 32039737

Group type: EXPERIMENTAL
Intervention: Biopsychosocial paediatric-adult transition programme (Arm B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (Arm A)
Number of subjects: 0
Study: 33658686

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 148

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 148